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coarctation was high. This study named this score as CoA - az score.
CONCLUSIONS Fetal echocardiography technology has diagnostic
value to the fetal aorta, middle cerebral artery and diagnostic signif-
icance of umbilical artery blood ﬂow ratio was obviously higher than
that of large arteries diameter ratio parameters, hints of ultrasonog-
raphy on diagnosis of aorta just according to the change of big blood
vessel diameter, at the same time should also pay attention to the
fetal head cycle to the placental circulation. Law of hemodynamic
ﬁndings can provide guidance for fetal echocardiography.
GW26-e4802
Congenital interrupted inferior vena cava: a rare risk factor for deep
venous thrombosis
Xiaoli Wang, Rongqin Zheng
The Third Afﬁliated Hospital of Sun Yat-sen University
OBJECTIVES To explore the clinical feature of congenital interrupted
inferior vena cava (IVC) with deep venous thrombosis (DVT).
METHODS Patients with DVT due to congenital interrupted inferior
vena cava were enrolled. Clinical and ultrasonography, CT, MRI
ﬁnding were analyzed retrospectively.
RESULTS Three patients were identiﬁed (two man and one woman)
between 2000 and 2015. Age at diagnosis was 17, 26, 28 years respectively.
One patient presented with swelling and tenderness of right crus. The
other two patients presented with left fossa iliaca pain and lower limbs
swelling and one of them with dyspnea, tachypnea. None of them had an
underlying coagulopathy or precipitating factors including immobiliza-
tion, surgery, oral contraceptive pills (OCPs), trauma, and malignancy.
Vascular ultrasound and computed tomography (CT) scan/MRI suggested
DVT (iliaca- femoral vein thrombosis in two and popliteal vein thrombosis
in one) and total interruption of IVC below the hepatic vein with azygos
continuation, draining into the superior vena cava. In patient presented
with dyspnea, tachypnea, MDCT demonstrated thrombus in the branch of
right pulmonary artery.
CONCLUSIONS In young patients with an idiopathic DVT, vascular
ultrasound and CT scan/MRI should be performed to evaluate the
venous system and rule out the rare possibility of an IVC anomaly.
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Transcatheter intervention of mesh-like ASD under TTE in infants
Silin Pan,1,2 Zhen Bing,1 Benzhen Wang,1 Kuiliang Wang,1
Guoying Huang2,2
1Qingdao Women and Children’s Hospital, Qingdao University;
2Children’s Hospital, Fudan University
OBJECTIVES To evaluate the availability transcatheter intervention
of mesh-like atrial septal defect(ASD)under transtothracic echocardi-
ography (TTE) in infants.
METHODS 27 cases with mesh-like ASD were enrolled in our group
between September 2007 and December 2012, 11 boys and 16 girls, 6
months to 11months (median 8.9months), bodyweight varying form 6
kg to 11kg (median 8.6kg). 2 patients associated with pulmonic ste-
nosis. The diagnosis was conﬁrmed by intraoperative angiography
and TTE. Echocardiography aimed at establishing the delivery
pathway and determining the plasticity of the implanted occluders,
especially to help to select the proper hole to implant the occluder.
RESULTS 26 cases underwent successful transcatheter invention with
one occlude each without residual shunt. The implanted occluder recoiled
with normal plasticity after being released. The other one was converted
to surgical repair after implantation for high-degree atrioventricular block.
CONCLUSIONS Transcatheter intervention of mesh-like ASD under
TTE in infants can safely work. Echocardiography plays a key role in
establishment of delivery pathway and deﬁnitive occluder releasing
during transcatheter intervention of these patients.RHEUMATIC AND VALVULAR HEART DISEASE
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Transcatheter paravalvular leakage interventionda new alternative for
open surgery?
Jian Yang, Yang Liu, Xiaofeng Li, Wensheng Chen, Shiqiang Yu
Department of Cardiovascular Surgery, Xining Hospital
OBJECTIVES To evaluate the safety and efﬁcacy of transcatheter inter-
vention of paravalvular leakage (PVL) after prosthetic valve replacement.METHODS From September 2011 to April 2015, 38 patients of para-
valvular leakage after prosthetic valve replacement underwent
interventional therapy. There were 30 male and 8 female, with mean
age¼ 50.813.4 (23-76) years old. 23 patients were diagnosed as aortic
PVL, 14 patients were diagnosed as mitral PVL and 1 patient was
diagnosed as tricuspid PVL. Previously, 35 patients underwent me-
chanical valve replacement and 3 patients had tissue valve replace-
ment, with 12 patients had a history of previous infective
endocarditis. There were 4 cases of NYHA heart function¼ II, 20
cases¼ III, and 14 cases¼ IV. The period of time between transcatheter
intervention and previous operation was 3.74.2 years, with PVL
regurgitation volume¼10.15.7 ml. Transcatheter intervention was
carried out in the catheterization laboratory or hybrid room with the
patient under local anesthesia or general anesthesia. By puncturing
femoral artery and implantation of different congenital heart disease
devices, the aortic PVL were occluded interventionally. Follow-up
evaluation included peri-operational mortality, complications and
postoperative residual shunt. The average follow-up time was 21
months (1-38 months).
RESULTS All the patients were successfully treated with trans-
catheter intervention and the success rate of transcatheter interven-
tion was 100%. 1 patients was implanted with 3 occluders, 5 patients
were implanted with 2 occluders with the other 32 patients had one
occluder each. In total, there were 8 muscular ventricular septal
defect occluders, 12 patent ductus arteriosus occluders and 25
vascular plugs. The average operation time was 92.827.2 min, and
the DSA radiation time were 20.312.2 min, with average hospitali-
zation time of 7.54.9 d. The main post-operative complications
included 3 cases transferred to open surgery (7.9%), 2 cases of he-
maturia needing dialysis (5.3%) and 3 cases of hematuria (7.9%).
During the follow-up, there was no death. PVL regurgitation volume
decreased to 1.10.7 ml (p<0.05) with improved heart function.
CONCLUSIONS The traditional treatment of paravalvular leakage af-
ter valve replacement need thoracotomy, extracorporeal circulation,
and open surgery. There was great trauma, high risk and many com-
plications. Transcatheter intervention of PVL has the advantages of
simpler and safe approach, less trauma, shorter time of hospitaliza-
tion, faster post-operative recovery and lower treatment cost. This
method is one of the new technologies in the ﬁeld of minimally
invasive cardiac surgery in recent years. By improving operation
skills, choosing individualized occluders and treatment of early he-
molytic complications, the success rate and long-term effect of
interventional therapy can get further improved. Transcatheter par-
avalvular leakage intervention could be a new alternative for open
surgery.GW26-e4766
A case-control study on risk factors of calciﬁc aortic valve disease in a
Chinese population
Dingji Zhu, Qingchun Zeng, Yunyi Zheng, Jinghai Hua, Dingli Xu
Department of Cardiology, Nanfang Hospital, Southern Medical
University
OBJECTIVES Calciﬁc aortic valve disease (CAVD) is one of the leading
cardiovascular diseases and affects a large number of old people. We
found that 12.8% of people older than 45 years suffered from CAVD.
However, the pathogenesis and risk factors of CAVD in the Chinese
population remains unclear. In this study, we collected clinical data
and analyzed the risk factors for CAVD.
METHODS The case-control study was performed in 2894 subjects
(age45) who had been examined in the Department of Cardiology in
Nanfang Hospital from 2005 to 2012. These subjects were divided into
two groups according to echocardiography results: CAVD group
(n¼1374) and control group (n¼1520). Detailed data on the patients
were collected and evaluated by univariate and multivariate logistic
regression analyses.
RESULTS A total of 2894 subjects were enrolled in this study. In CAVD
group, 24 of 1374 patients (2%) suffered from calciﬁc aortic valve
stenosis, 918 of 1374 patients (67%) suffered from calciﬁc aortic valve
insufﬁciency, 154 of 1374 patients (11%) suffered from both calciﬁc
aortic stenosis and aortic valve insufﬁciency, and 278 of 1374 patients
(20%) suffered from aortic valve calciﬁcation without calciﬁc aortic
stenosis or aortic valve insufﬁciency. To screen out the candidate risk
factors, a univariate factor logistic regression analysis was used to
analyze the clinical data in CAVD group and control group. The results
showed that gender (P¼0.003, OR¼0.797), age (P¼0.000, OR¼1.196),
aortic atherosclerosis (P¼0.000, OR¼13.68), BMI (P¼0.000,
OR¼0.896), eGFR (P¼0.000, OR¼0.947), Cr (P¼0.000, OR¼1.034),
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phils (P¼0.000, OR¼1.586), CRP (P¼0.000, OR¼1.175), TG (P¼0.000,
OR¼1.156), TC (P¼0.000, OR¼0.825), LDL-C (P¼0.000, OR¼0.558),
BUN (P¼0.000, OR¼1.460), UA (P¼0.005, OR¼1.001), and HCY
(P¼0.000, OR¼1.226) were candidate risk factors for calciﬁc aortic
valve disease. To further conﬁrm the risk factors of CAVD, a multi-
factor logistic regression analysis was performed to evaluate the sig-
niﬁcance. The results showed that age (P¼0.001, OR¼1.099), gender
(P¼0.045, OR¼0.367), pro-BNP (P¼0.007, OR¼1.005), HCY(P¼0.014,
OR¼1.105), and aortic atherosclerosis (P¼0.004, OR¼15.197) were
signiﬁcantly correlated with CAVD.
CONCLUSIONS Aortic atherosclerosis has a strongly positive associ-
ation with CAVD, and it may predict this disease. Besides aortic
atherosclerosis, high levels of age, pro-BNP, and HCY increase the risk
of CAVD. Interestingly, women were more likely to suffer from CAVD.
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D-dimer predicts all-cause mortality and cardiovascular events in Patients
receiving warfarin treatment after went mechanical heart valve
replacement
Litao Zhang, Zhenlu Zhang
Wuhan Asia Heart Hospital
OBJECTIVES The aim of the present research was to investigate
whether D-dimer can predict all-cause mortality and cardiovascular
events in patients suffered mechanical heart valve replacement
(MHVR) during warfarin treatment.
METHODS This was a prospective and observational study. 1163 Pa-
tients after going mechanical valve replacement (5012yrs, Male:
42.1%) and treated with warfarin for at least 3 months were enrolled.
D-dimer levels and Prothrombin time derived international normal-
ized ratio(PT-INR) were monitored by once two months. (Target INR
1.5 to 2.5 in aortic valve replacement (AVR), 2.0-3.0 in mitral valve
replacement(MVR) or double valve replacement (DVR, AVRþMVR),
Followed-up by phonecall and patients visiting our outpatients
department until the end points. And the end points were cardio-
vascular events(thromboembolic events, ischemic stroke, myocardial
infarction, cerebral hemorrhages) and death from any cause.
RESULTS The D-dimer assay was abnormal(>255ng/ml, DDU) in 191 of
1163 patients(16.4%). During an average follow-up period of 3014
months(1-54months), A total of 42 cardiovascular events and 40
deaths occurred among the 191 patients who had elevated D-dimer, as
compared with 47cardiovascular events and 52 deaths among 972
patients(4.0%) had normal D-dimer levels(255ng/ml); Log-rank test
revealed that patients with elevated D-dimer levels experienced
higher cardiovascular events(Harzard ratio:12.82, 95% CI of ratio:7.15-
22.98, p<0.0001) and all-cause mortality (Harzard ratio:9.36, 95% CI
of ratio:5.28-16.60, p<0.0001).
CONCLUSIONS D-dimer might be a useful marker to predict cardio-
vascular events and all-cause mortality in patients receiving warfarin
anticoagulation after mechanical heart valve replacement.
(ClinicalTrials.gov Identiﬁer: NCT01996657 ).
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Genetic Polymorphisms of PXR and POR are Associated with Increased
Warfarin Maintenance Dose in Han Chinese
Wutao Zeng,1 Qishan Zheng,3 Chenghsun Li,1 Jiali Li,1 Xiuyu Leng,1
Hanjing Cen,2 Lizi Zhao,2 Min Huang2
1The First Afﬁliated Hospital of Sun Yat-sen University, Guangzhou,
China; 2School of Pharmaceutical Sciences, Sun Yat-sen University,
Guangzhou, China; 3Zhongshan Afﬁliated Hospital of Sun Yat-sen
University, Zhongshan, China
OBJECTIVES The aim of this current study is to explore whether PXR,
POR, and CYP2C9 IVS3 -65G>C are the upstream factors impacting on
individual variability of warfarin maintenance dose in Han Chinese.
METHODS The genotypes of NR1I2 -25385C>T, NR1I2 7635G>A, POR
A503V, POR 831 -35C>T, and CYP2C9 IVS3 -65G>C were detected by
PCR-restriction fragment length polymorphism (RFLP) in 188 Han
Chinese patients with mechanical heart valve replacement. The sta-
tistics were analyzed by ANOVA and multiple linear regression.
RESULTS The warfarin maintenance dose was higher in patients with
the SNP of NR1I2 7635 GA/AA alleles than those in GG group (GA:
3.001.40 mg/d vs. 2.471.43 mg/d, P < 0.05; AA: 2.921.40 mg/d vs.
2.471.43 mg/d, P < 0.01). The patients with POR 831 -35 CT/TT alleles
took signiﬁcantly higher warfarin maintenance dose than those in CCgroup (2.901.40 mg/d, 3.051.55 mg/d vs. 2.551.36 mg/d, P < 0.05,
respectively). Compared with the alleles of CYP2C9 IVS3 -65, the warfarin
maintenance does in GC group was signiﬁcantly higher than that in GG
group (4.001.44 mg/d vs. 2.781.41 mg/d, P < 0.01). The multiple
regression model including genotypes of PXR, POR, VKORC1, CYP2C9,
CYP4F2, and clinical factors interpreted 57.5% of warfarin maintenance
dose variance, where NR1I2 7635G>A, POR 831 -35C>T, and CYP2C9 IVS3
-65G>C contributed 1.4%, 2.1%, and 1.9% respectively.
CONCLUSIONS The SNPs NR1I2 7635G>A, POR 831 -35C>T, and
CYP2C9 IVS3 -65G>C are signiﬁcant factors to individual variability of
warfarin maintenance dose in Han Chinese.
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The ACE2-Ang(1-7)-Mas Axis may be the angel and play the protective role
in the occurrence and maintaining of Atrial Fibrillation in The Patients with
Rheumatic Valvular Heart Disease
Yongrong Jiang, Junqiang Pan, Xin Zhou, Chaofeng Sun
The First Afﬁliated Hospital of Xi’an Jiaotong University
OBJECTIVES By analysis of the correlation between the expression of
the ACE2-Ang(1-7)-Mas axis in the patients with rheumatic valvular
heart disease and the occurrence of atrial ﬁbrillation, to reveal the
function of the ACE2-Ang(1-7)-Mas axis in the occurrence and main-
taining of atrial ﬁbrillation and to ﬁnd new targets for the prevention
and treatment of atrial ﬁbrillation.
METHODS Collect the basic information, examination results, pe-
ripheral venous blood and right atrium tissues of the patients with
rheumatic heart valve disease who accepted the cardiac valve pros-
theses (total 60 patients, including 32 with AF and 28 with SR).Use
ELISA kits to detect the ACE, ACE2, Ang (1-7) and Ang IIconcentrations
in the serum samples, real-time ﬂuorescent quantitative PCR to detect
the relative mRNA expression of ACE, ACE2, Ang (1-7), Ang II, Mas and
AT1 receptor in atrial tissues.At last, analysis the difference and cor-
relation between the two groups.All the patients agreed and signed
informed consent before participating in the study.
RESULTS In the AF group, (1) the diameter of left atrium is signiﬁcantly
greater than the SR group(60.70 3.08 & 48.15 2.16 mm, p<0.05);(2) the
serum concentration of ACE (246  12.87 & 135.78  11.08 pg/ml, p <0.05),
AngII(45.88  2.87 & 35.78  1.08 pg/ml, p <0.05) and relative mRNA
expression of ACE(2-▵▵CT: 4.54  1.38 & 1.00  0.17, p <0.05), AngII(2-
▵▵CT: 3.99  1.21 & 1.00  0.43, p <0.05) and AT1 receptor in the atrial
tissues (2-▵▵CT: 6.17  1.19 & 1.00  0.003, p <0.05) are obviously higher
than that of the SR group, positively correlated with the left atrium
diameter (Pearson test, p <0.05);(3) the serum concentration of ACE2 (7.87
 0.74 & 11.65  0.57U/L, p <0.05), Ang (1-7) (146.05  17.61 & 321.71 
36.50 pg/ml, p <0.05) and relative mRNA expression of ACE2 (2-▵▵CT:
0.40 0.12 & 1.00 0.21, p <0.05), Ang (1-7) (2-▵▵CT: 0.60 0.11 & 1.00 
0.16, p <0.05) is signiﬁcantly lower than the SR group, and negatively
correlated with left atrium diameter (Pearson test, p <0.05), however, the
Mas receptor (2-▵▵CT: 4.89  0.81 & 1.00  0.26, p <0.05) is signiﬁcantly
higher than the SR group, positively correlated with the left atrium
diameter and the relative expression of AT1 receptor (Pearson test,
p <0.05).(4) the serum concentration and relative mRNA expression of
ACE and ACE2, Ang (1-7) and AngIIis negatively correlated(Pearson test,
p <0.05).
CONCLUSIONS For the patients with rheumatic valvular heart disease,
the axis of ACE2-Ang(1-7) - Mas may be the antagonism to the axis of ACE-
AngII- AT1, and by this way inhibits the atrial remodeling, and plays a
protective role on the occurrence and maintaining of atrial ﬁbrillation.
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Analysis of clinical symptoms of 67 cases of infective endocarditis
Faquan Li,1 Wei Liao,1 Menghong Wang2
1The Afﬁliated Hospital of Gannan Medical University; 2The Afﬁliated
Hospital of Nanchang University
OBJECTIVES To investigate the infective endocarditis (infective endo-
carditis, IE), pathogens, clinical features and treatment strategies.
METHODS A retrospective analysis of clinical data of the First Afﬁli-
ated Hospital of Nanchang University about ﬁve years, 67 cases of IE.
RESULTS Streptococcus viridans accounted for 36.8%, 6 cases of Staph-
ylococcus aureus accounted for 31.6%. Structural heart disease, 59 cases
(88.1%), rheumatic heart disease in 22 cases (37.2%), including two cases
of prosthetic valve, congenital heart disease in 25 cases (42.3%). Ultra-
sound technology in the detection rate of cardiac neoplasm in 56 cases
(83.5%), the positive rate is much higher than the blood culture.
